ABCB1 Gene rs2032582: What Your Genotype Means
The rs2032582 variant is a well-studied, tri-allelic genetic change (2677T>G/A) located in the ABCB1 gene, which plays a crucial role in how the body transports and clears medications. Research associates this variant with differences in drug response and a varying susceptibility to inflammatory bowel disease across different populations.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| TT | Homozygous for the T allele, coding for serine at position 893. This genotype is associated with baseline P-glycoprotein function, though it may influence the response to certain medications like SNRIs. Research on its exact impact remains mixed. | Informational |
| GG | Homozygous for the G allele, coding for alanine. This genotype has been statistically associated with an altered risk for inflammatory bowel disease in specific populations, particularly in Asian ancestries. It may also affect how the body clears certain drugs. | Higher attention |
| AA | Homozygous for the A allele, coding for threonine. This is a relatively rare genotype across most global populations. Its specific independent effects on drug transport and disease risk are less thoroughly documented than the T and G alleles. | Informational |
| TG | Heterozygous, carrying one T allele and one G allele. Individuals with this genotype produce a mix of P-glycoprotein variants. The clinical impact on drug transport and disease risk is generally intermediate and heavily influenced by other genetic and environmental factors. | Informational |
| TA | Heterozygous, carrying one T allele and one A allele. This genotype results in a combination of serine and threonine amino acids in the P-glycoprotein structure. It is relatively uncommon and its clinical significance is still being studied. | Informational |
| GA | Heterozygous, carrying one G allele and one A allele. This combination is rare and produces a mix of alanine and threonine variants of the transport protein. Evidence regarding its specific impact on health and medication response is currently limited. | Informational |
What is rs2032582 and the ABCB1 Gene?
The rs2032582 variant is located on chromosome 7 within the ABCB1 gene, historically known as MDR1. This gene provides instructions for making P-glycoprotein (P-gp), an essential protein that acts as an ATP-dependent drug efflux pump. P-glycoprotein sits in cell membranes and actively pumps foreign substances, including many common medications and toxins, out of cells. This process is a critical part of the body's defense system, directly influencing how drugs are absorbed in the intestines, distributed through the blood-brain barrier, and excreted by the liver and kidneys. The rs2032582 variant is a missense mutation, meaning it changes a single amino acid in the resulting protein (specifically, Ser893Ala or Ser893Thr). Because it is tri-allelic, the DNA letter at this position can be a T, G, or A. These subtle structural changes can alter how efficiently P-glycoprotein transports its substrates, making this variant a major focus in pharmacogenomics, which is the study of how genes affect a person's response to drugs.
Pharmacogenomics and Drug Response
Because P-glycoprotein interacts with a vast array of medications, researchers have extensively studied rs2032582 to understand its impact on drug efficacy and side effects. The variant has been investigated in relation to antidepressants like SNRIs, blood thinners such as rivaroxaban, statins, and immunosuppressants used after organ transplants. For example, some studies suggest that individuals with the TT genotype may experience different clinical responses to certain antidepressants compared to those with G or A alleles. However, the scientific evidence remains mixed and highly complex. According to the Pharmacogenomics Knowledgebase, the clinical evidence for rs2032582 altering antidepressant efficacy is currently considered Level 3, meaning the associations are recognized but may lack the definitive consensus required to change standard medical practice. The impact of this variant often depends heavily on the specific drug being taken, the presence of other genetic variants, and environmental factors. Therefore, while rs2032582 is a strong candidate for influencing drug disposition, it is rarely used in isolation to determine prescriptions.
Association with Inflammatory Bowel Disease
Beyond drug transport, rs2032582 has been strongly linked to a person's susceptibility to inflammatory bowel disease, a condition characterized by chronic inflammation of the gastrointestinal tract. The ABCB1 gene is highly expressed in the intestines, where it helps maintain the barrier against gut bacteria and toxins. Reduced function of P-glycoprotein could theoretically allow more inflammatory triggers to breach the intestinal lining. Large meta-analyses have demonstrated that the rs2032582 variant is significantly associated with inflammatory bowel disease risk, but this effect is highly dependent on a person's ancestry. The statistical association is most prominent in Asian and African populations, where specific alleles correlate with an increased risk of developing the disease, particularly Crohn's disease. In contrast, studies focusing on Caucasian populations have generally found no significant association between this variant and disease susceptibility. This highlights the importance of genetic background when interpreting the clinical relevance of rs2032582, as the same genetic change can have vastly different implications depending on a person's ethnicity.
What You Can and Cannot Do With This Information
If you discover your rs2032582 genotype through a direct-to-consumer DNA test, it is important to view the results as educational rather than diagnostic. While this variant is a well-documented factor in pharmacogenomics and inflammatory bowel disease research, it does not guarantee that you will develop a gastrointestinal condition, nor does it mean a specific medication will definitively fail or cause side effects. The human body's processing of drugs is incredibly complex, relying on multiple genes, liver enzymes, diet, age, and overall health. You cannot use this genetic information to self-diagnose or independently alter your medication dosages. Doing so can be dangerous and lead to adverse health outcomes. If you are taking medications known to be transported by P-glycoprotein and you have concerns about their efficacy or side effects, you should share your genetic report with a healthcare provider. Always discuss potential dosing adjustments or alternative therapies with a qualified clinician or pharmacist who can evaluate your complete medical profile.
How common is this variant?
The frequency of the rs2032582 alleles varies significantly across different global populations. For example, the T allele frequency ranges from as low as 2% to as high as 65% depending on ethnic background, with the A allele generally being the rarest.
Frequently asked questions
What is the ABCB1 gene?
The ABCB1 gene provides instructions for making P-glycoprotein, a crucial protein that pumps foreign substances and drugs out of cells. It plays a major role in protecting the body from toxins and determining how medications are absorbed and excreted.
Does the rs2032582 variant mean my medications won't work?
No. While rs2032582 can influence how efficiently your body transports certain drugs, it is only one of many factors that determine medication efficacy. You should never stop or change your medication based on this genetic result without consulting a doctor.
Is rs2032582 linked to Crohn's disease?
Yes, research has found a statistical association between this variant and susceptibility to inflammatory bowel diseases, including Crohn's disease. However, this association is mostly observed in Asian and African populations, and having the variant does not guarantee you will develop the condition.
Why does this variant have three different letters (T, G, A)?
Most genetic variants involve a swap between just two DNA letters, but rs2032582 is tri-allelic, meaning three different variations can occur at this specific location. Each letter codes for a slightly different amino acid, which can subtly alter the shape and function of the resulting protein.
Should I get tested for the ABCB1 rs2032582 variant?
Routine testing for this specific variant is not currently standard medical practice for most conditions. However, it is often included in comprehensive pharmacogenomic panels that doctors may order if you are experiencing unusual side effects or poor responses to certain medications.
Sources & further reading
Educational information only, last refreshed 9/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2032582?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCB1
Synonymous polymorphism in the ABCB1 (MDR1) transporter gene influencing substrate drug efflux and systemic drug exposure.
Synonymous exon 26 variant in ABCB1 linked to altered mRNA stability and variable response to multiple cardiovascular medications.
Influences the expression of P-glycoprotein, impacting the transport and clearance of numerous medications including digoxin and certain statins.
This variant in the multidrug resistance gene can affect the transport and efficacy of various medications.